Morgan Stanley’s SCYNEXIS SCYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.8K Sell
3,109
-2,653
-46% -$16.4K ﹤0.01% 6672
2025
Q4
$29.1K Buy
5,762
+3,799
+194% +$20.7K ﹤0.01% 6582
2025
Q3
$12.1K Hold
1,963
﹤0.01% 6847
2025
Q2
$10.6K Hold
1,963
﹤0.01% 6847
2025
Q1
$14.9K Hold
1,963
﹤0.01% 6669
2024
Q4
$19K Hold
1,963
﹤0.01% 6585
2024
Q3
$23.4K Sell
1,963
-514
-21% -$7.27K ﹤0.01% 6454
2024
Q2
$39.6K Sell
2,477
-749
-23% -$11.6K ﹤0.01% 6241
2024
Q1
$37.9K Sell
3,226
-699
-18% -$9.88K ﹤0.01% 6317
2023
Q4
$70K Buy
3,925
+2,350
+149% +$34.5K ﹤0.01% 6278
2023
Q3
$28.7K Hold
1,575
﹤0.01% 6369
2023
Q2
$37.2K Hold
1,575
﹤0.01% 6328
2023
Q1
$37.8K Sell
1,575
-624
-28% -$8.29K ﹤0.01% 6384
2022
Q4
$27.4K Buy
2,199
+436
+25% +$7.71K ﹤0.01% 6548
2022
Q3
$34K Buy
1,763
+100
+6% +$1.96K ﹤0.01% 6573
2022
Q2
$25K Buy
1,663
+1,014
+156% +$19.5K ﹤0.01% 6902
2022
Q1
$20K Sell
649
-977
-60% -$37.4K ﹤0.01% 7156
2021
Q4
$79K Sell
1,626
-4,860
-75% -$239K ﹤0.01% 6574
2021
Q3
$275K Buy
6,486
+2,670
+70% +$140K ﹤0.01% 5831
2021
Q2
$225K Buy
3,816
+3,300
+640% +$208K ﹤0.01% 5952
2021
Q1
$33K Buy
516
+204
+65% +$13.4K ﹤0.01% 6547
2020
Q4
$19K Buy
312
+187
+150% +$8.76K ﹤0.01% 6448
2020
Q3
$4K Buy
+125
New +$6.12K ﹤0.01% 6479
2018
Q4
Sell
-125
Closed -$12K 6713
2018
Q3
$12K Buy
125
+121
+3,025% +$14.3K ﹤0.01% 6273
2018
Q2
$0 Hold
4
﹤0.01% 6735
2018
Q1
$0 Buy
+4
New +$552 ﹤0.01% 6682
2017
Q3
Hold
0
6596
2017
Q2
Hold
0
6640
2016
Q4
Sell
-25
Closed -$8K 6557
2016
Q3
$8K Sell
25
-92
-79% -$19.4K ﹤0.01% 6153
2016
Q2
$20K Buy
+117
New +$33.1K ﹤0.01% 5854
2016
Q1
Hold
0
6690
2015
Q3
Hold
0
6700
2015
Q2
Hold
0
6730
2015
Q1
Sell
-5
Closed -$4.1K 6632
2014
Q4
$4K Buy
+5
New +$3.54K ﹤0.01% 6370
2014
Q3
Sell
-25
Closed -$16K 6648
2014
Q2
$16K Buy
+25
New +$17.5K ﹤0.01% 6081

Other funds holding SCYX

Morgan Stanley's SCYX Position: Q1 2026 in Review

Morgan Stanley reduced its SCYNEXIS (SCYX) stake by 46% in Q1 2026, selling an estimated $16.4K and leaving 3,109 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #6672.

Morgan Stanley first reported a position in SCYX in Q2 2014 and has held it in 30 quarters since. The position peaked at $275K in Q3 2021. 46 funds tracked by Wall St. Rank hold SCYX as of Q1 2026.

  • Morgan Stanley held 3,109 shares of SCYNEXIS worth $22.8K as of Q1 2026.
  • Morgan Stanley sold 2,653 SCYNEXIS shares in Q1 2026, an estimated $16.4K.
  • SCYNEXIS made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6672 holding.
  • Morgan Stanley first reported a position in SCYNEXIS in Q2 2014 and has held it in 30 quarters since.
  • Morgan Stanley's SCYNEXIS position peaked at $275K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.